Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 116

Sort by

Sort Order Select

Journal Articles

Clinical Determinants of Early Mortality Following Allotransplantation for Acute Lymphoblastic Leukemia in a Brazilian Multicenter Registry

Dalila Cysne, Wellington F Silva, Mariana Nassif Kerbauy, Iago Colturato, Ana Maia, Luciana Tucunduva, George Barros, Vergilio Colturato, Nelson Hamerschlak, Vanderson Rocha

Blood (2023) 142 (Supplement 1): 2167.

https://doi.org/10.1182/blood-2023-182057

Published: 2023

Journal Articles

Dynamics of Immune Reconstitution after Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide Compared to Classical Immunosuppression with ATG

Mariana Nassif Kerbauy, Fernanda Agostini Rocha, Leonardo Javier Arcuri, Priscila Silva Cunegundes, Clarisse MARTINS Machado, Andreza Feitosa Ribeiro, Lucila Nassif Kerbauy, Luciana Cavalheiro Marti, Nelson Hamerschlak

Blood (2023) 142 (Supplement 1): 3574.

https://doi.org/10.1182/blood-2023-188052

Published: 2023

Journal Articles

Role of Splenic Irradiation Prior to Transplant for Myelofibrosis: A Global Collaboration

Nico Gagelmann, Gabriela S. Hobbs, Edoardo Campodonico, Polona Novak, Vaneuza Funke, Vanderson Rocha, Nelson Hamerschlak, Thomas Schroeder, Christina Rautenberg, Linette Bosques, Raffaella Greco, Artur Schneider, Grzegorz Helbig, Nicolaus Kroeger

Blood (2023) 142 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2023-191300

Published: 2023

Journal Articles

Brazilian Non-Hodgkin T Cell Registry: An Exploratory Analysis of Extranodal Sites

Blood (2023) 142 (Supplement 1): 3118.

https://doi.org/10.1182/blood-2023-188361

Published: 2023

Journal Articles

Development of a Modified Prognostic Index for Adult Patients with Acute Lymphoblastic Leukemia

Eduardo Cerello Chapchap, Ana Luisa Oliveira, Maria Eduarda Alonso Joaquim de Carvalho, Mireia Morgades, Vitor AQ Mauad, Davimar Miranda Maciel Borducchi, Fabio P. S. Santos, Jordi Ribera, Fabio R. Kerbauy, Josep-Maria Ribera, Nelson Hamerschlak

Blood (2023) 142 (Supplement 1): 1460.

https://doi.org/10.1182/blood-2023-184869

Published: 2023

Journal Articles

Hematological Parameters: Comparative Evaluation of Performance between Dxh 500 and XN-10 Equipments

Viviane Regina Regina Hernandez Hernandez Nunes, Rosana Moreira Cosentino Penteado, Andrea Tiemi Kondo, Afonso Cardoso, Nelson Hamerschlak, Alfredo Mendrone, Andrea Rocco Villarinho, Denise Cristine de Oliveira, Joao Carlos de Campos Guerra

Blood (2023) 142 (Supplement 1): 6946.

https://doi.org/10.1182/blood-2023-182429

Published: 2023

Journal Articles

Real World Data on Treatment of Acute Myeloid Leukemia (AML) in a Private Healthcare Institution in Brazil, a Low-Middle Income Country - Importance of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Carolina Perrone Marques, Carolina Leme de Moura Pereira, Jade Zezzi Nascimento, Tarcila Santos Datoguia, Felipe Galvão Batista Chaves, Juliana Dall Agnol Rocha, Amanda Inácio Dias Ennes, Eduardo Cerello Chapchap, Paulo Vidal Campregher, Leonardo Javier Arcuri, Andreza Feitosa Ribeiro, Nelson Hamerschlak, Fabio P. S. Santos

Blood (2023) 142 (Supplement 1): 7440.

https://doi.org/10.1182/blood-2023-191152

Published: 2023

Journal Articles

Outcomes of Conservative Indication Criteria for First-Line Treatment in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry of CLL

Blood (2023) 142 (Supplement 1): 6534.

https://doi.org/10.1182/blood-2023-190590

Published: 2023

Journal Articles

Next Generation Sequencing and Cytogenetics in Acute Myeloid Leukemia - Therapeutic and Prognostic Impact: A Retrospective Cohort from a Private Centre of Reference in Latin America

Felipe Galvão Batista Chaves, Juliana Dall'Agnol da Rocha, Leonardo Javier Arcuri, Paulo Vidal Campregher, Fabio P. S. Santos, Carolina Perrone Marques, Jade Zezzi Martins do Nascimento, Tarcila Santos Datoguia, Amanda Inácio Dias Ennes, Rodrigo Seiti Kojima, Nelson Hamerschlak

Blood (2023) 142 (Supplement 1): 5981.

https://doi.org/10.1182/blood-2023-190992

Published: 2023

Journal Articles

Evaluation of the Impact of the Disease Risk Index and Pre-Transplant Measurable Residual Disease By Flow Cytometry As Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia

Carolina Perrone Marques, Ana Carolina de Almeida Silveira, Jade Zezzi, Felipe Galvão Batista Chaves, Juliana Dall'Agnol da Rocha, Renata Leati Stanzione, Mariana Nassif Kerbauy, Nelson Hamerschlak, Fabio P. S. Santos, Leonardo Javier Arcuri, Andreza Feitosa Ribeiro

Blood (2023) 142 (Supplement 1): 7438.

https://doi.org/10.1182/blood-2023-190786

Published: 2023

Journal Articles

Real World Data Venetoclax Based Therapies in a Single Center in Latin America

Juliana Dall Agnol Rocha, Leonardo Javier Arcuri, Rodrigo Seiti Kojima, Nelson Hamerschlak, Fabio P. S. Santos, Amanda Inácio Dias Ennes, Tarcila Santos Datoguia, Jade Zezzi Nascimento, Carolina Perrone Marques, Felipe Galvão Batista Chaves, Luiz Frederico Bezerra Honorato Junior, Barbara Ferreira Cordeiro Galvao

Blood (2023) 142 (Supplement 1): 7441.

https://doi.org/10.1182/blood-2023-191182

Published: 2023

Journal Articles

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Molly Tokaz, Helen Baldomero, Andrew J Cowan, Wael Saber, Hildegard T. Greinix, Mickey Koh, Nicolaus Kröger, Mohamad Mohty, Sebastian Galeano, Shinichiro Okamoto, Naeem A. Chaudhri, Amado J Karduss, Fabio Ciceri, Vergilio Rensi Colturato, Selim Corbacioglu, Alaa M. Elhaddad, Lisa Force, Cristobal Augusto Frutos Ortiz, Andres Gomez-De Leon, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius YL Ho, Xiao-Jun Huang, Benjamin Jacobs, Heeje Kim, Minako Iida, Leslie E. Lehmann, Régis Peffault de Latour, Mary-Elizabeth M. Percival, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor-Sheng Ko, Anderson Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A Snowden, Daniel J. Weisdorf, Jakob R. Passweg, Marcelo C Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser, Martina Perdomo

Blood (2022) 140 (Supplement 1): 8146–8149.

https://doi.org/10.1182/blood-2022-158338

Published: 2022

Journal Articles

Clinical Validation of Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of B Neoplasia

Lucila Kerbauy, Larissa Leggieri Coa, Micheli Severo Sielski, Juliana Aparecida Preto Godoy, Andrea Tiemi Kondo, Julia Teixeira Cottas Azevedo, Augusto Barbosa, Jr., Oswaldo Keith Okamoto, Jose Mauro Kutner, Nelson Hamerschlak, Raquel de Melo Alves Paiva

Blood (2022) 140 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2022-170045

Published: 2022

Journal Articles

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Leonardo Javier Arcuri, Fabio Pires de Souza Santos, Lucila Kerbauy, Mariana Nassif Kerbauy, Andreza Feitosa Ribeiro, Nelson Hamerschlak

Blood (2022) 140 (Supplement 1): 4767–4769.

https://doi.org/10.1182/blood-2022-156282

Published: 2022

Journal Articles

Does Prompt Access to Healthcare Impact the Outcomes of Hodgkin Lymphoma? a Comparison between Public and Private Patients Sharing the Same Infrastructure

Carolina C P Feres, Larissa LC Teixeira, Leonardo Javier Arcuri, Gabriela Amaral Vieira, Carolina Leme de Moura Pereira, Nelson Hamerschlak, Guilherme Fleury Perini

Blood (2022) 140 (Supplement 1): 3707–3708.

https://doi.org/10.1182/blood-2022-170514

Published: 2022

Journal Articles

Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL

Marcelo Pitombeira de Lacerda, Fernanda de Morais Marques, Verena Pfister, Flavia de Carvalho Parra, Vinicius Campos de Molla, Valeria Buccheri, Rafael Dezen Gaiolla, Laura Maria Fogliatto, Rodrigo Santucci, Marcelo Bellesso, Sérgio Costa Fortier, Talita M.B. Silveira, Glaciano Ribeiro, Nelson Hamerschlak, Mihoko Yamamoto, Matheus Vescovi Goncalves, Carlos S. Chiattone, Celso Arrais-Rodrigues

Blood (2022) 140 (Supplement 1): 7041–7042.

https://doi.org/10.1182/blood-2022-170872

Published: 2022

Journal Articles

Treatment of COVID-19 Patients: Insights into the Use of Bone Marrow-Derived Mesenchymal Stem Cells

Heitor Duarte Andrade, Andrea Tiemi Kondo, Lucila Kerbauy, Raquel de Melo Alves Paiva, Denise Cristine Oliveira, Larissa Leggieri Coa, Kelen Cristina Arcuri Alvarez, Mariana Lorenzi Savioli, Bruna Melo Coelho Loureiro, Oswaldo Keith Okamoto, Nelson Hamerschlak, Jose Mauro Kutner, Juliana Aparecida Preto Godoy

Blood (2021) 138 (Supplement 1): 4302.

https://doi.org/10.1182/blood-2021-154291

Published: 2021

Journal Articles

Identification of Gene Networks Associated with the Anti-Leukemic Effect of Anti-Inflammatory Drugs on Acute Myeloid Leukemia Cell Lines

Victória Tomaz, Karina Griesi-Oliveira, Renato D Puga, Fabio Pires de Souza Santos, Nelson Hamerschlak, Paulo Vidal Campregher

Blood (2021) 138 (Supplement 1): 4343.

https://doi.org/10.1182/blood-2021-153903

Published: 2021

Journal Articles

Patient-Reported-Outcomes on Diagnosis, Treatment and Adverse Effects Following Acute Lymphoblastic Leukemia in a Low-Middle-in-Come Country: Cross-Sectional Study

Eduardo Cerello Chapchap, Nelson Hamerschlak, Nina Melo, Maria Lucia De Martino Lee, Denise Martins

Blood (2021) 138 (Supplement 1): 4375.

https://doi.org/10.1182/blood-2021-145435

Published: 2021

Journal Articles

Risk Factors for Adverse Outcomes Following Haploidentical Hematopoietic Cell Transplantation with Posttransplant Cyclophosphamide: A Two-Center Analysis

Viviane De Jesus Torres Lima, Anderson Felipe Felipe Da Silva, Andreza Alice Feitosa Ribeiro, Mariana Nassif Kerbauy, Lucila Kerbauy, Cinthya Correa Silva, Leonardo Javier Arcuri, Nelson Hamerschlak

Blood (2021) 138 (Supplement 1): 4889.

https://doi.org/10.1182/blood-2021-153961

Published: 2021

NARROW

Clinical Determinants of Early Mortality Following Allotransplantation for Acute Lymphoblastic Leukemia in a Brazilian Multicenter Registry

Dynamics of Immune Reconstitution after Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide Compared to Classical Immunosuppression with ATG

Role of Splenic Irradiation Prior to Transplant for Myelofibrosis: A Global Collaboration

Brazilian Non-Hodgkin T Cell Registry: An Exploratory Analysis of Extranodal Sites

Development of a Modified Prognostic Index for Adult Patients with Acute Lymphoblastic Leukemia

Hematological Parameters: Comparative Evaluation of Performance between Dxh 500 and XN-10 Equipments

Real World Data on Treatment of Acute Myeloid Leukemia (AML) in a Private Healthcare Institution in Brazil, a Low-Middle Income Country - Importance of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Outcomes of Conservative Indication Criteria for First-Line Treatment in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry of CLL

Next Generation Sequencing and Cytogenetics in Acute Myeloid Leukemia - Therapeutic and Prognostic Impact: A Retrospective Cohort from a Private Centre of Reference in Latin America

Evaluation of the Impact of the Disease Risk Index and Pre-Transplant Measurable Residual Disease By Flow Cytometry As Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia

Real World Data Venetoclax Based Therapies in a Single Center in Latin America

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Clinical Validation of Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of B Neoplasia

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Does Prompt Access to Healthcare Impact the Outcomes of Hodgkin Lymphoma? a Comparison between Public and Private Patients Sharing the Same Infrastructure

Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL

Treatment of COVID-19 Patients: Insights into the Use of Bone Marrow-Derived Mesenchymal Stem Cells

Identification of Gene Networks Associated with the Anti-Leukemic Effect of Anti-Inflammatory Drugs on Acute Myeloid Leukemia Cell Lines

Patient-Reported-Outcomes on Diagnosis, Treatment and Adverse Effects Following Acute Lymphoblastic Leukemia in a Low-Middle-in-Come Country: Cross-Sectional Study

Risk Factors for Adverse Outcomes Following Haploidentical Hematopoietic Cell Transplantation with Posttransplant Cyclophosphamide: A Two-Center Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only